Aisling Capital Partners III LLC, 10% Owner at Loxo Oncology, Inc. (LOXO), bought 78,669 shares at $27.65 ($2.2M) on 2015-11-12, disclosed to the SEC on 2015-11-16.
Open-market purchase of $2.2M LOXO by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.65 | 76,714 | $2.1M | 97.5% |
| 2 | $27.47 | 1,955 | $54K | 2.5% |
| Total | $27.65 avg | 78,669 | $2.2M | 100% |
| Filing → |
| LOXO | BUY | 2016-05-19 | $5.0M | — | Filing → |
| TTOO | BUY | 2015-12-09 | $3.0M | — | Filing → |
| LOXO | BUY | 2015-11-19 | $7.0M | — | Filing → |